Back to Journals » Clinical Ophthalmology » Volume 13
Corrigendum
A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,584 | Dovepress* | 5,377+ | 1,468 | 6,845 | |
PubMed Central* | 207 | 78 | 285 | ||
Totals | 5,584 | 1,546 | 7,130 | ||
*Since 24 January 2019 |
View citations on PubMed Central and Google Scholar